ATE163768T1 - Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden - Google Patents

Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden

Info

Publication number
ATE163768T1
ATE163768T1 AT92921544T AT92921544T ATE163768T1 AT E163768 T1 ATE163768 T1 AT E163768T1 AT 92921544 T AT92921544 T AT 92921544T AT 92921544 T AT92921544 T AT 92921544T AT E163768 T1 ATE163768 T1 AT E163768T1
Authority
AT
Austria
Prior art keywords
tissue factor
phospholipids
recombinant human
human tissue
sythetic
Prior art date
Application number
AT92921544T
Other languages
English (en)
Inventor
Pamela L Hawkins
Liliana Tejidor
James Maynard
Kevin B Johnson
Original Assignee
Dade Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Int Inc filed Critical Dade Int Inc
Application granted granted Critical
Publication of ATE163768T1 publication Critical patent/ATE163768T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
AT92921544T 1991-10-04 1992-09-25 Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden ATE163768T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77129491A 1991-10-04 1991-10-04

Publications (1)

Publication Number Publication Date
ATE163768T1 true ATE163768T1 (de) 1998-03-15

Family

ID=25091357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921544T ATE163768T1 (de) 1991-10-04 1992-09-25 Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden

Country Status (11)

Country Link
US (1) US5625036A (de)
EP (1) EP0565665B1 (de)
JP (1) JP3416778B2 (de)
AT (1) ATE163768T1 (de)
AU (1) AU663343B2 (de)
CA (1) CA2097199C (de)
DE (1) DE69224622T2 (de)
DK (1) DK0565665T3 (de)
ES (1) ES2115679T3 (de)
NZ (1) NZ244597A (de)
WO (1) WO1993007492A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418141A (en) * 1994-05-06 1995-05-23 Avocet Medical, Inc. Test articles for performing dry reagent prothrombin time assays
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
AT403437B (de) * 1995-02-15 1998-02-25 Immuno Ag Physiologisch aktive gewebefaktor-präparation
CA2236155A1 (en) * 1995-11-22 1997-05-29 Oklahoma Medical Research Foundation Assay for blood clotting factors viii and ix
US5858724A (en) * 1996-07-16 1999-01-12 Pel-Freez Recombinant rabbit tissue factor
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
DE69832628T2 (de) * 1997-04-23 2006-09-07 Instrumentation Laboratory S.P.A. Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
AU9114598A (en) * 1997-08-26 1999-03-16 University Of North Carolina At Chapel Hill, The Method of monitoring blood low molecular weight heparin and heparin
US6245573B1 (en) 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
EP1031830B8 (de) 1999-02-23 2009-12-09 Asulab S.A. Elektrochemisches System zur Bestimmung der Blutgerinnungszeit
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
US6699718B1 (en) * 1999-09-03 2004-03-02 Roche Diagnostics Corporation Method, reagent and test cartridge for determining clotting time
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7049087B2 (en) 2002-11-05 2006-05-23 Lifescan, Inc. Method for manufacturing a tissue factor-based prothrombin time reagent
AU2003282351A1 (en) * 2002-11-12 2004-06-03 Inverness Medical Switzerland Gmbh Photometric determination of coagulation time in undiluted whole blood
US7604932B2 (en) * 2002-11-13 2009-10-20 Haematologic Technologies, Inc. Assay for tissue factor in a sample
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
DE602006021290D1 (de) 2005-03-04 2011-05-26 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
JP5073270B2 (ja) 2006-11-14 2012-11-14 シスメックス株式会社 凝固検査用試薬及びその製造方法
EP2040073A1 (de) * 2007-09-20 2009-03-25 Iline Microsystems, S.L. Mikrofluidische Vorrichtung und Verfahren zur Flüssigkeitsgerinnungs-Zeitbestimmung
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
WO2011144953A1 (en) * 2010-05-18 2011-11-24 Diagon Kft. Procedure for producing recombinant human tissue factor
CN103003441A (zh) 2010-05-28 2013-03-27 戴阿冈有限公司 脂质体的两相制备方法及其在制造诊断试剂中的应用
CN102608337B (zh) * 2011-04-22 2014-05-14 武汉塞力斯生物技术有限公司 凝血酶原时间测定试剂盒及其制备方法
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法
CN115508569A (zh) * 2022-09-15 2022-12-23 上海太阳生物技术有限公司 蛋白s试剂及检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
SE458342B (sv) * 1987-07-06 1989-03-20 Alfa Laval Ab Centrifugalseparator innefattande en rotor med en separeringskammare bestaaende av tvaa avdelningar
US4865984A (en) * 1988-02-08 1989-09-12 Mount Sinai School Of Medicine Of The City University Of New York Dynamic continuous flow enzyme reactor
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent

Also Published As

Publication number Publication date
CA2097199C (en) 2001-05-08
EP0565665A1 (de) 1993-10-20
JP3416778B2 (ja) 2003-06-16
US5625036A (en) 1997-04-29
DE69224622D1 (de) 1998-04-09
WO1993007492A1 (en) 1993-04-15
DE69224622T2 (de) 1998-11-05
AU663343B2 (en) 1995-10-05
DK0565665T3 (da) 1998-09-28
CA2097199A1 (en) 1993-04-05
NZ244597A (en) 1993-09-27
AU2769292A (en) 1993-05-03
JPH06505562A (ja) 1994-06-23
ES2115679T3 (es) 1998-07-01
EP0565665B1 (de) 1998-03-04

Similar Documents

Publication Publication Date Title
ATE163768T1 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
Stenner et al. Human platelets contain and secrete osteonectin, a major protein of mineralized bone.
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
DE59912393D1 (de) Vakzinformulierung enthaltend Zuckeralkohol und niedrige Konzentrationen anorganischer Ionen
Shomers et al. Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva
DE68918155D1 (de) Chirurgisches Klebstoffmaterial.
FI902249A0 (fi) Foerfarande foer framstaellning av liposomer med foerbaettrad stabilitet under torkning.
DE69231469D1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
DE59009034D1 (de) Desodorierende kosmetische mittel.
DE510721T1 (de) Methode und zusammensetzungen zur erzeugung verstaerkter chemilumineszenz von 1,2-dioxetanen.
NO883926L (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
TW364850B (en) Nematocidal compositions
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DK524884A (da) Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf
BG49719A3 (en) Method for preparing of variants chirudine and their use
Saito et al. Fletcher factor activity in plasmas of various species
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
SE8502540D0 (sv) Stable dentifrice containing dextranase
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
ATE195322T1 (de) Verwendung von oberflächenaktiven substanzen zur stabilisierung von peptiden und proteinen zur radiopharmazeutischen verwendung
Psuja et al. Binding of heparin to human endothelial cell monolayer and extracellular matrix in culture
ATE106570T1 (de) Verfahren zur bestimmung von fructosamin.
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification